David Scott Jones - Feb 9, 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
SVP & Chief Commercial Officer
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Feb 9, 2022
Transactions value $
-$14,921
Form type
4
Date filed
2/11/2022, 03:39 PM
Previous filing
Nov 3, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +4.97K +54.39% $0.00 14.1K Feb 9, 2022 Direct F1
transaction EYPT Common Stock Tax liability -$14.9K -1.47K -10.45% $10.13 12.6K Feb 9, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +15K $0.00 15K Feb 9, 2022 Common Stock 15K $0.00 Direct F3
transaction EYPT Restricted Stock Units Options Exercise $0 -4.97K -33.33% $0.00 9.93K Feb 9, 2022 Common Stock 4.97K $0.00 Direct F4
transaction EYPT Stock Option (Right to Buy) Award $0 +60K $0.00 60K Feb 9, 2022 Common Stock 60K $10.13 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 886 shares acquired on July 30, 2021 and 865 shares acquired on January 31,2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
F2 No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F3 The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
F4 The restricted stock units vest in three ratable annual installments beginning February 9, 2022.
F5 The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years.